Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
Chemotherapy and bevacizumab is given for 4 months. Patients who have not progressed will
continue with maintenance treatment with either bevacizumab (Avastin) alone, or bevacizumab
and erlotinib (Tarceva).